graduates have gone on to head clinical departments in the US, particularly because we have an FTA with India, where one of the commitments is to open up our medical register. We are not opening up yet, because there is still disagreement with India. India wants every medical school in India to be recognised. I cannot accept that, because we all know there is a wide range of standards and we cannot just open the door to every Indian medical graduate. But there are two, three or four very good medical schools. Entry is so competitive that one must be absolutely bright to be able to enter, and their graduates are proving themselves in the US and Europe. I think there is no reason why we should exclude these top medical schools and their graduates from coming here to help us make Singapore a regional medical hub. The SMC is actively reviewing the subject, and will progressively expand the list. I expect to make the first announcement soon.Microsoft has decided to extend their skunk works to Changi General Hospital and even enlarge the scope of their work to include the community hospitals and nursing homes that partner Changi General Hospital in providing integrated care.behalf of their patients. This will be welcome by their patients, I am sure. Such transparency will also help convince their foreign patients that Singapore offers very competitive pricing for healthcare services.Mdm Halimah asked if our healthcare model can cope with the ageing of our population. In particular, what about the healthcare needs of our future elderly? Will 3Ms be enough? This is really a very dynamic situation with many unknowns. What are the new technologies that are coming in? At what cost? What are the changing population attitudes towards sickness, health, etc? And, of course, how much can we afford, which is economic growth? That is why I agree with Mdm Halimah that we need to periodically review and update our 3M system. And we do. Last year, we updated MediShield. This year, my focus is on Medisave. We do allow Medisave for medical insurance. I believe in Medisave insurance, because pooling of risks is a very important part of healthcare financing. But Medisave must not unwittingly support comprehensive medical insurance which will only lead to disappointment and very high healthcare costs. This is not a theoretical argument. The argument has already been settled empirically. We only need to see the experiences of those countries with such comprehensive medical insurance schemes. Let us not repeat the mistakes of others. They are now trying to get out of that hole. Let us not walk into that hole. on Class B2, which is heavily subsidised and, therefore, we keep the subsidy for Singaporeans and, in fact, at the moment, also PRs. But non-citizens are not included. quantum. Relying on memory here, I think you can claim up to $6,000 for IVF, which will therefore cover items like drugs, etc. But we made a distinct decision to limit it to three treatment cycles, and the reason is properly and rationally grounded. You can check the data on the success rate. Each time the couples repeat, it is greater and greater disappointment and, after the third cycle, the chance of a success is very, very low, and you are really throwing away a lot of money. Yes, maybe we are a little bit paternalistic here by saying that Medisave ought to be for other uses and therefore we limit it to three cycles. But it is for a very good reason. If we just open it up - imagine $6,000 per treatment - and we have, say, run it to five cycles, that is a lot of thousands of dollars. Medisave, even though it is significant for some middle-income group, there is an upper bound to it. So it is not as if it is a lot of money and you can just waste it to pursue IVF and the various techniques. So I hope Mr Chiam can accept that explanation.